Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2WT8Y
|
|||
| Drug Name |
V212
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Herpes zoster [ICD-11: 1E91; ICD-9: 53] | Phase 3 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01229267) A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.